FDA approves Hibsago (bepirovirsen) with NrtI therapy for adult chronic hepatitis B without cirrhosis; phase 3 trials show up to 20% functional cure at 72 weeks.

The FDA approved bepirovirsen, the first antisense oligonucleotide for chronic hepatitis B, offering a new treatment with functional cure potential. Bepirovirsen is specifically approved for patients ...

An experimental therapy kept the virus at bay for at least six months. The approach could target other stubborn viruses too. Viruses are sneaky things. When they die, their DNA often sticks around.

How to use a laser level for beginners. Lock vs unlock self-leveling mode, plumb bob to transfer points from floor to ceiling, and left-right micro adjust.I used the plumb dot to hang LED hexagon ...

If you're a new electric vehicle owner, you may be surprised to learn just how many charging options you have available, both at home and to extend your range on the road. While the industry has ...

Level-5 has openly admitted to using AI in game development. This has prompted fans to analyze the studio's game trailers for evidence of AI — even when it may not exist. During this month's Nintendo ...

Chronic hepatitis B (CHB) frequently coexists with metabolic dysfunction–associated fatty liver disease (MAFLD), yet the impact of MAFLD on hepatitis B virus (HBV) replication remains incompletely ...

Americans who may be planning a trip to Libya are being urged to reconsider those plans, as the U.S. State Department has issued its strongest possible travel warning. The department recently updated ...

Silver nanoparticles can precisely slice DNA and create longer “sticky ends,” helping genetic fragments join up to five times more efficiently than conventional methods. The breakthrough could ...

The study findings support the use of bepirovirsen as a finite-duration therapy capable of achieving sustained off-treatment viral control. Functional cure of chronic hepatitis B virus (HBV) infection ...

The novel antisense oligonucleotide bepirovirsen targeting hepatitis B virus (HBV) transcripts holds promise of a functional cure, at least in the short term, according to phase 3 results from the ...